243 Unveiling the Role of the Most Impactful Cardiovascular Risk Locus through Haplotype Editing.
https://www.cell.com/cell/fulltext/S0092-8674(18)31506-X
242 Profiling proliferative cells and their progeny in damaged murine hearts.
https://www.pnas.org/content/115/52/E12245
241 Cardiac cell–integrated microneedle patch for treating myocardial infarction.
http://advances.sciencemag.org/content/4/11/eaat9365
240 Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
https://www.nejm.org/doi/full/10.1056/NEJMoa1801174?query=featured_home
239 Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31719-7/fulltext
238 A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest.
https://www.nejm.org/doi/full/10.1056/NEJMoa1806842
237 Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.
https://www.nejm.org/doi/full/10.1056/NEJMoa1805971?query=featured_home
236 A coupled-clock system drives the automaticity of human sinoatrial nodal pacemaker cells.
http://stke.sciencemag.org/content/11/534/eaap7608
235 The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery.
http://stm.sciencemag.org/content/10/441/eaan4886
234 PPARγ agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.
http://stm.sciencemag.org/content/10/438/eaao0303
|
